{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:25:22Z","timestamp":1775305522513,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T00:00:00Z","timestamp":1325203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00204-011-0799-6","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T11:55:05Z","timestamp":1325159705000},"page":"725-731","source":"Crossref","is-referenced-by-count":17,"title":["Dominant lethal mutations of topoisomerase II inhibitors etoposide and merbarone in male mice: a mechanistic study"],"prefix":"10.1007","volume":"86","author":[{"given":"Sabry M.","family":"Attia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,30]]},"reference":[{"key":"799_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0027-5107(95)00223-5","volume":"352","author":"ID Adler","year":"1996","unstructured":"Adler ID (1996) Comparison of the duration of spermatogenesis between male rodents and humans. Mutat Res 352:169\u2013172","journal-title":"Mutat Res"},{"issue":"4","key":"799_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/mutage\/10.4.343","volume":"10","author":"S Albertini","year":"1995","unstructured":"Albertini S, Chetelat AA, Miller B, Muster W, Pujadas E, Strobel R, Gocke E (1995) Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 10(4):343\u2013351","journal-title":"Mutagenesis"},{"key":"799_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0027-5107(95)00041-G","volume":"330","author":"J Ashby","year":"1995","unstructured":"Ashby J, Clapp MJL (1995) The rodent dominant lethal assay: a proposed format for data presentation that alerts to pseudo dominant lethal effects. Mutat Res 330:209\u2013218","journal-title":"Mutat Res"},{"issue":"1","key":"799_CR4","first-page":"1","volume":"17","author":"SM Attia","year":"2008","unstructured":"Attia SM (2008) Mutagenicity of some topoisomerase II-interactive agents. SPJ 17(1):1\u201324","journal-title":"SPJ"},{"issue":"4","key":"799_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4161\/oxim.3.4.13246","volume":"3","author":"SM Attia","year":"2010","unstructured":"Attia SM (2010) Deleterious effects of reactive metabolites. Oxid Med Cell Longev 3(4):238\u2013253","journal-title":"Oxid Med Cell Longev"},{"issue":"1\u20132","key":"799_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1383-5718(02)00079-7","volume":"520","author":"SM Attia","year":"2002","unstructured":"Attia SM, Schmid TE, Badary OA, Hamada FM, Adler ID (2002) Molecular cytogenetic analysis in mouse sperm of chemically induced aneuploidy: studies with topoisomerase II inhibitors. Mutat Res 520(1\u20132):1\u201313","journal-title":"Mutat Res"},{"issue":"2","key":"799_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/em.10135","volume":"41","author":"SM Attia","year":"2003","unstructured":"Attia SM, Kliesch U, Schriever-Schwemmer G, Badary OA, Hamada FM, Adler ID (2003) Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe. Environ Mol Mutagen 41(2):99\u2013103","journal-title":"Environ Mol Mutagen"},{"issue":"4","key":"799_CR8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00280-009-0934-8","volume":"64","author":"SM Attia","year":"2009","unstructured":"Attia SM, Al-Anteet AA, AL-Rasheed NM, Alhaider AA, Al-Harbi MM (2009) Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane. Cancer Chemother Pharmacol 64(4):837\u2013845","journal-title":"Cancer Chemother Pharmacol"},{"key":"799_CR9","doi-asserted-by":"crossref","first-page":"365292","DOI":"10.1155\/2011\/365292","volume":"2011","author":"SA Bakheet","year":"2011","unstructured":"Bakheet SA, Attia SM (2011) Evaluation of chromosomal instability in diabetic rats treated with naringin. Oxid Med Cell Longev 2011:365292. doi: 10.1155\/2011\/365292","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"799_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/mutage\/ger013","volume":"26","author":"SA Bakheet","year":"2011","unstructured":"Bakheet SA, Attia SM, AL-Rasheed NM, Al-harbi MM, Ashour AE, Korashy HM, Abd-Allah AR, Saquib Q, Al-Khedhairy AA, Musarrat J (2011) Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells. Mutagenesis 26(4):533\u2013543","journal-title":"Mutagenesis"},{"key":"799_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-4781(98)00132-8","volume":"1400","author":"DA Burden","year":"1998","unstructured":"Burden DA, Osheroff N (1998) Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1400:139\u2013154","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"799_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-4274(02)00482-4","volume":"142","author":"G Chamorro","year":"2003","unstructured":"Chamorro G, Vega F, Madrigal E, Mercado E, Salazar M (2003) Germ cell mutagenicity of gamma-ethyl-gamma-phenyl-butyrolactone (EPBL) detected in the CF1 mouse-dominant lethal study. Toxicol Lett 142(1\u20132):37\u201343","journal-title":"Toxicol Lett"},{"key":"799_CR13","first-page":"1509","volume":"55","author":"M Chen","year":"1995","unstructured":"Chen M, Beck WT (1995) Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26. Cancer Res 55:1509\u20131516","journal-title":"Cancer Res"},{"issue":"2","key":"799_CR14","first-page":"217","volume":"13","author":"F D\u2019Agostini","year":"1998","unstructured":"D\u2019Agostini F, Bagnasco M, Giunciuglio D, Albini A, De Flora S (1998) Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice. Int J Oncol 13(2):217\u2013224","journal-title":"Int J Oncol"},{"issue":"10","key":"799_CR15","first-page":"2578","volume":"49","author":"FH Drake","year":"1989","unstructured":"Drake FH, Hofmann GA, Mong SM, Bartus JO, Hertzberg RP, Johnson RK, Mattern MR, Mirabelli CK (1989) In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res 49(10):2578\u20132583","journal-title":"Cancer Res"},{"key":"799_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00368226","volume":"39","author":"UH Ehling","year":"1978","unstructured":"Ehling UH, Machemer L, Buselmaier W, D\u00fdcka J, Frohberg H, Kratochvilova J, Lang R, Lorke D, M\u00fcller D, Peh J, R\u00f6thrborn G, Roll R, Schulze-Schencking M, Wiemann H (1978) Standard protocol for the dominant lethal test on male mice. Arch Toxicol 39:173\u2013185","journal-title":"Arch Toxicol"},{"key":"799_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-291X(86)90965-4","volume":"135","author":"N Haim","year":"1986","unstructured":"Haim N, Roman J, Nemec J, Sinha BK (1986) Peroxidative free radical formation and O-demethylation of etoposide (VP-16) and teniposide (VM-26). Biochem Biophys Res Commun 135:215\u2013220","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"799_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0027-5107(01)00303-7","volume":"500","author":"AM Jha","year":"2002","unstructured":"Jha AM, Bharti MK (2002) Mutagenic profiles of carbazole in the male germ cells of Swiss albino mice. Mutat Res 500(1\u20132):97\u2013101","journal-title":"Mutat Res"},{"key":"799_CR19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/mol.56.3.494","volume":"56","author":"VE Kagan","year":"1999","unstructured":"Kagan VE, Yalowich JC, Borisenko GG, Tyurina YY, Tyurin VA, Thampatty P, Fabisiak JP (1999) Mechanism based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical\/antioxidant approach. Mol Pharmacol 56:494\u2013506","journal-title":"Mol Pharmacol"},{"key":"799_CR20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/mutage\/11.5.435","volume":"11","author":"M Kallio","year":"1996","unstructured":"Kallio M, L\u00e4hdetie J (1996) Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide. Mutagenesis 11:435\u2013443","journal-title":"Mutagenesis"},{"key":"799_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-2280(1997)29:1<16::AID-EM3>3.0.CO;2-B","volume":"29","author":"M Kallio","year":"1997","unstructured":"Kallio M, L\u00e4hdetie J (1997) Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: cell cycle arrest and induction of aneuploidy. Environ Mol Mutagen 29:16\u201327","journal-title":"Environ Mol Mutagen"},{"issue":"2","key":"799_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","volume":"99","author":"AK Larsen","year":"2003","unstructured":"Larsen AK, Escargueil AE, Skladanowski A (2003) Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther 99(2):167\u2013181","journal-title":"Pharmacol Ther"},{"key":"799_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0145-2126(79)90033-X","volume":"3","author":"BB Lozzio","year":"1979","unstructured":"Lozzio BB, Lozzio CB (1979) Properties and usefulness of the original K562 human myelogenous leukemia cell line. Leuk Res 3:363\u2013370","journal-title":"Leuk Res"},{"key":"799_CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/mutage\/11.4.357","volume":"11","author":"JB Mailhes","year":"1996","unstructured":"Mailhes JB, Marchetti F, Young D, London SN (1996) Numerical and structural chromosome aberrations induced by etoposide (VP-16) during oocyte maturation of mice: transmission to one-cell zygotes and damage to dictyate oocytes. Mutagenesis 11:357\u2013361","journal-title":"Mutagenesis"},{"issue":"4","key":"799_CR25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/humrep\/dei416","volume":"21","author":"F Marchetti","year":"2006","unstructured":"Marchetti F, Pearson FS, Bishop JB, Wyrobek AJ (2006) Etoposide induces chromosomal abnormalities in mouse spermatocytes and stem cell spermatogonia. Hum Reprod 21(4):888\u2013895","journal-title":"Hum Reprod"},{"issue":"3","key":"799_CR26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0090-9556(25)07394-5","volume":"21","author":"JF Muindi","year":"1993","unstructured":"Muindi JF, Stevens YW, Warrell RP Jr, Young CW (1993) In vitro differential metabolism of merbarone by xanthine oxidase and microsomal flavoenzymes. The role of reactive oxygen species. Drug Metab Dispos 21(3):410\u2013414","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"799_CR27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1124\/jpet.103.063347","volume":"309","author":"EA Neuwelt","year":"2004","unstructured":"Neuwelt EA, Pagel MA, Kraemer DF, Peterson DR, Muldoon LL (2004) Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model. J Pharmacol Exp Ther 309(2):594\u2013599","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"799_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0027-5107(98)00036-0","volume":"400","author":"LB Russell","year":"1998","unstructured":"Russell LB, Hunsicker PR, Johnson DK, Shelby MD (1998) Unlike other chemicals, etoposide (a topoisomerase-II inhibitor) produces peak mutagenicity in primary spermatocytes of the mouse. Mutat Res 400(1\u20132):279\u2013286","journal-title":"Mutat Res"},{"issue":"6","key":"799_CR29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.molcel.2004.08.018","volume":"15","author":"DA Skoufias","year":"2004","unstructured":"Skoufias DA, Lacroix FB, Andreassen PR, Wilson L, Margolis RL (2004) Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase. Mol Cell 15(6):977\u2013990","journal-title":"Mol Cell"},{"key":"799_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0027-5107(01)00101-4","volume":"476","author":"H Tateno","year":"2001","unstructured":"Tateno H, Kamiguchi Y (2001) Meiotic stage-dependent induction of chromosome aberrations in Chinese hamster primary oocytes exposed to topoisomerase II inhibitor etoposide. Mutat Res 476:139\u2013148","journal-title":"Mutat Res"},{"issue":"4","key":"799_CR31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/em.10072","volume":"39","author":"L Wang","year":"2002","unstructured":"Wang L, Eastmond DA (2002) Catalytic inhibitors of topoisomerase II are DNAdamaging agents: induction of chromosomal damage by merbarone and ICRF-187. Environ Mol Mutagen 39(4):348\u2013356","journal-title":"Environ Mol Mutagen"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-011-0799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-011-0799-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-011-0799-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:34:26Z","timestamp":1742175266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-011-0799-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,30]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1007\/s00204-011-0799-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,30]]}}}